Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Status:
Terminated
Trial end date:
1998-01-22
Target enrollment:
Participant gender:
Summary
Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit
to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may
prove beneficial in the treatment of Stage IV Cancer of the Cervix and/or Vulva.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Stage IV Cancer of the Cervix and/or Vulva.